Long classified as a subset of common liver cancer, FLC should be considered its own unique disease. Now researchers are testing a combination drug therapy that targets FLC tumors. Like many rare ...

Here, we report that TRAIL is constitutively expressed on murine natural killer (NK) cells in the liver and plays a substantial role in suppressing tumor metastasis. Freshly isolated NK cells ...

These findings may shape the future of liver cancer treatment, demonstrating that reducing BAAT and increasing UDCA can control tumor growth and improve T cell and immunotherapy efficacy.

These findings may shape the future of liver cancer treatment, demonstrating that reducing BAAT and increasing UDCA can control tumor growth and improve T cell and immunotherapy efficacy.